Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
an opening for an expert on lipid nanoparticle-mediated gene delivery to hematopoietic stem cells and other cells and tissues. In this novel line of research, we aim to establish non-viral approaches
-
stem and progenitor cells), RNA (miR/anti-miR, synthetic modified RNA) and pharmacological approaches. One major goal is the establishment of a human umbilical cord stem cell program. Your Profile
-
experience in Hematology Oncology, Stem Cell Transplant, and/or Medical ICU. NP II California Nurse Practitioner Furnishing License At least one (1) year of recent clinical experience as a Nurse Practitioner
-
) mediate differentiation of induced pluripotent stem cells into cardiovascular lineages, and 2) biomaterials that mediate transdifferentiation of somatic cells into cardiovascular lineage. In particular, we
-
, fibrosis, inflammation, and stem cell studies ● Perform proteomic analysis and molecular biology techniques ● Maintain the records and laboratory work areas and ensures that areas are clean and adequately
-
strong background in cell culture and the desire to support our stem cell-based cardiac research. Your main responsibilities are The expansion of human induced pluripotent stem cells (iPSCs) and their
-
explores genetic causes of neurological disorders and aim to develop therapies for these conditions with a high complementary approach, ranging from stem cell modelling to functional genomic. Information
-
School. The goal of our research program is to elucidate the molecular and cellular mechanisms involved in brain tumor formation, and the role of specific signaling pathways and stem cells in tumor
-
background in stem cell biology, neurobiology or developmental biology, and an appetite for quantitative data. Prior mass spectrometry experience is welcome but not required; we will train you. 2. Clinical
-
peripheral blood stem cell transplantation and tumor models. Studies may also include use of human cells and humanized NSG mouse models. Ongoing research includes novel approaches in activating anti-tumor